In this study, we provide evidence that sorafenib ameliorates CCl4‐induced liver fibrosis by triggering ferroptosis in HSCs through HIF‐1α/SLC7A11 pathway. This evidence concerns the gene SLC7A11 and Hepatic fibrosis.